Brain glucose transport and phosphorylation under acute insulin-induced hypoglycemia in mice: an 18F-FDG PET study

J Nucl Med. 2013 Dec;54(12):2153-60. doi: 10.2967/jnumed.113.122812. Epub 2013 Oct 24.

Abstract

We addressed the questions of how cerebral glucose transport and phosphorylation change under acute hypoglycemia and what the underlying mechanisms of adaptation are.

Methods: Quantitative (18)F-FDG PET combined with the acquisition of real-time arterial input function was performed on mice. Hypoglycemia was induced and maintained by insulin infusion. PET data were analyzed with the 2-tissue-compartment model for (18)F-FDG, and the results were evaluated with Michaelis-Menten saturation kinetics.

Results: Glucose clearance from plasma to brain (K1,glc) and the phosphorylation rate constant increased with decreasing plasma glucose (Gp), in particular at a Gp of less than 2.5 mmol/L. Estimated cerebral glucose extraction ratios taking into account an increased cerebral blood flow (CBF) at a Gp of less than 2 mmol/L were between 0.14 and 0.79. CBF-normalized K1,glc values were in agreement with saturation kinetics. Phosphorylation rate constants indicated intracellular glucose depletion at a Gp of less than 2-3 mmol/L. When brain regions were compared, glucose transport under hypoglycemia was lowest in the hypothalamus.

Conclusion: Alterations in glucose transport and phosphorylation, as well as intracellular glucose depletion, under acute hypoglycemia can be modeled by saturation kinetics taking into account an increase in CBF. Distinct transport kinetics in the hypothalamus may be involved in its glucose-sensing function.

Keywords: Michaelis–Menten kinetics; brain glucose metabolism; hypoglycemia; positron-emission tomography.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biological Transport / drug effects
  • Blood-Brain Barrier / drug effects
  • Blood-Brain Barrier / metabolism
  • Brain / diagnostic imaging
  • Brain / drug effects
  • Brain / metabolism*
  • Brain / physiopathology
  • Cerebrovascular Circulation / drug effects
  • Fluorodeoxyglucose F18*
  • Glucose / metabolism*
  • Hypoglycemia / chemically induced
  • Hypoglycemia / diagnostic imaging*
  • Hypoglycemia / metabolism*
  • Hypoglycemia / physiopathology
  • Insulin / pharmacology*
  • Kinetics
  • Male
  • Mice
  • Organ Specificity
  • Permeability / drug effects
  • Phosphorylation / drug effects
  • Positron-Emission Tomography*

Substances

  • Insulin
  • Fluorodeoxyglucose F18
  • Glucose